Search images on Google Product Monograph
Active Ingredients:
- zanamivir, 5 MG/ACT
DIN: 02240863
Dosage Form(s): POWDER
Route(s) of Administration: INHALATION, ORAL
Schedule: Prescription
Company: GLAXOSMITHKLINE INC – official site
ATC:
- J05 - ANTIVIRALS FOR SYSTEMIC USE (ATC, WHO, Wiki)
- J05A - DIRECT ACTING ANTIVIRALS (ATC, WHO)
- J05AH - Neuraminidase inhibitors (ATC, WHO)
- J05AH01 - ZANAMIVIR (WHO)
Reference brand drug: Relenza
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 5MG BLISTER
External Links for Relenza:
Search on Google
Glaxosmithkline Inc
Go to GlaxoSmithKline website to see drug product details. Sometimes you can find relenza photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.